New registry aims to improve survival in pulmonary hypertension emergencies
NCT ID NCT06923917
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow 200 adults with pulmonary arterial hypertension who experience a sudden worsening of right heart failure. Researchers will collect medical data to see how many survive or need a lung transplant within 3 and 12 months. The goal is to identify better ways to manage these critical episodes across different European hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assistance Publique hopitaux de Paris
Le Kremlin-Bicêtre, 94270, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scoliosis's hidden toll: can we predict lung and heart risks?
- Which breathing setting keeps Kids' lungs healthier during heart surgery?
- Could a simple sleep guide ease insomnia in lung disease?
- A Needle-Free heart check? MRI may replace invasive catheterization
- Can a diabetes drug help the lungs? pioglitazone put to the test for pulmonary hypertension
- Zapping lung nerves could ease heart Failure-Related high blood pressure